Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
Frequently Asked Questions
What is Market Cap of Advanced Life Sciences Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Advanced Life Sciences Holdings Inc market cap is N/A.
What is the 52-week high for Advanced Life Sciences Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Advanced Life Sciences Holdings Inc 52 week high is N/A as of September 28, 2025.
What is the 52-week low for Advanced Life Sciences Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Advanced Life Sciences Holdings Inc 52 week low is N/A as of September 28, 2025.
What is Advanced Life Sciences Holdings Inc stock price today?
Advanced Life Sciences Holdings Inc stock price today is $0.01.
What was Advanced Life Sciences Holdings Inc stock price yesterday?
Advanced Life Sciences Holdings Inc stock price yesterday was $0.01.
What is the PE ratio of Advanced Life Sciences Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Advanced Life Sciences Holdings Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Advanced Life Sciences Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Advanced Life Sciences Holdings Inc P/B ratio is None.
What is Advanced Life Sciences Holdings Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Advanced Life Sciences Holdings Inc's EBITDA is N/A.
What is the 50-day moving average of Advanced Life Sciences Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Advanced Life Sciences Holdings Inc 50-day moving average is N/A.
How many employess does Advanced Life Sciences Holdings Inc has?
Advanced Life Sciences Holdings Inc has N/A employees.